Presentation Topic: The # 1 Killer Worldwide Cardiovascular Disease: Implications for T-Cell Immunotherapeutic and Covid-19 on the Incidence and Severity of Cardiovascular Events
Provided by: James C. Keith, Jr., DVM, PH.D
Classification: Chief Scientific Officer
Business: EmstoPA, Ltd
Occasion: 3rd Meridian Drug Discovery
Organizer: Continuum Globe Ltd.
Date: 18 & 19 th of November 2021
Useful Links:
EmstoPA, Ltd.: http://emstopa.com
Continuum Globe Ltd: https://continuumglobe.com
Meridian Drug Discovery series: https://meridiandrugdiscovery.com
Meridian Drug Discovery USA: https://meridiandrugdiscovery.com/usa
In case you missed out on the previous variation of the Meridian Drug Discovery series. Contact us at info@continuumglobe.com to get info about the previous and approaching programs.
Follow us on LinkedIn, Twitter, Facebook, Pinterest, and Instagram for future updates:
Linkedin: https://www.linkedin.com/company/cont …
Twitter: https://twitter.com/ContinuumGlobe
Facebook: https://www.facebook.com/continuumglobe
Pinterest: https://www.pinterest.co.uk/continuum …
Instagram: https://www.instagram.com/continuumglobe
#Pharma #Biotech #Events #summits #2021 #covid-19 #drugdiscovery #MDD #CGL #virtualevents #james #EmstoPA #Immunotherapeutic.
http://medicaltranscriptionprograms.com/the-1-killer-worldwide-cardiovascular-disease-implications-for-t-cell-immunotherapeutic-covid-19/
No comments:
Post a Comment